AMS - IM - Women's Health: Benign Breast Disease; Endometriosis; Premenstrual Syndrome (USB Flash Drive)

$189.00


Topics and Objectives

Title: Internal Medicine – Women’s Health: Benign Breast Disease; Endometriosis; Premenstrual Syndrome
Faculty: Herbert L. Muncie, Jr., M.D., Albert J. Peters, D.O., F.A.C.O.G.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Evaluation and Initial Management: Benign Breast Disease

Upon completion of this session, using the American Cancer Society Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

  1. Differentiate the signs and symptoms associated with benign breast disease.
  2. Formulate an evaluation for breast pain (mastalgia), breast lumps, and nipple discharge.
  3. Specify the treatment options for breast pain, nipple discharge and breast infections.
  4. Distinguish the symptoms and physical findings associated with rare benign breast disease conditions.

TOPIC 2: Endometriosis.

Upon completion of this session, using ACOG Practice Guidelines and Practice Committee Guidelines – ASRM, the participant should be able to: GL, , COMP

  1. Have a high degree of accuracy in the suspicion of endometriosis based on symptoms and physical examination.
  2. Review current management options with particular attention toward agents that can be effectively used by the primary care provider.
  3. Guide patients with regard to long-term management for pain and/or fertility considerations.
  4. Understand the risks and benefits of various treatment options for endometriosis as well as recurrence risk.

TOPIC 3: Premenstrual Syndrome.

Upon completion of this session, using ACOG Guidelines and NIH Guidelines, the participant should be able to: GL, COMP

  1. Correctly diagnose patients with this disorder using NIH guidelines.
  2. Utilize current effective and FDA-approved therapies.
  3. Formulate an appropriate differential diagnosis for PMS.

StreamingINCLUDED
Total Cost: $

    Title: Internal Medicine – Women’s Health: Benign Breast Disease; Endometriosis; Premenstrual Syndrome
    Faculty: Herbert L. Muncie, Jr., M.D., Albert J. Peters, D.O., F.A.C.O.G.

    Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

    TOPIC 1: Evaluation and Initial Management: Benign Breast Disease

    Upon completion of this session, using the American Cancer Society Guidelines and the Cochrane Abstract Database, the participant should be able to: EBM, GL, COMP

    1. Differentiate the signs and symptoms associated with benign breast disease.
    2. Formulate an evaluation for breast pain (mastalgia), breast lumps, and nipple discharge.
    3. Specify the treatment options for breast pain, nipple discharge and breast infections.
    4. Distinguish the symptoms and physical findings associated with rare benign breast disease conditions.

    TOPIC 2: Endometriosis.

    Upon completion of this session, using ACOG Practice Guidelines and Practice Committee Guidelines – ASRM, the participant should be able to: GL, , COMP

    1. Have a high degree of accuracy in the suspicion of endometriosis based on symptoms and physical examination.
    2. Review current management options with particular attention toward agents that can be effectively used by the primary care provider.
    3. Guide patients with regard to long-term management for pain and/or fertility considerations.
    4. Understand the risks and benefits of various treatment options for endometriosis as well as recurrence risk.

    TOPIC 3: Premenstrual Syndrome.

    Upon completion of this session, using ACOG Guidelines and NIH Guidelines, the participant should be able to: GL, COMP

    1. Correctly diagnose patients with this disorder using NIH guidelines.
    2. Utilize current effective and FDA-approved therapies.
    3. Formulate an appropriate differential diagnosis for PMS.
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.